Dongfeng F. Chen
232 Waihuan East Road
Guangzhou, 510006, China
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 236 publications
Correction: Epigenetic restriction of Hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells.
Journal: Cell death and differentiation
Published: March 11, 2026
Development and Validation of a Prediction Model for Overt Hepatic Encephalopathy (OHE) After Transjugular Intrahepatic Portosystemic Shunt: A Multicenter Retrospective Study.
Journal: Journal of clinical and experimental hepatology
Published: November 12, 2025
Macrophage-derived DLL4 promotes liver fibrosis by activating the Notch pathway in hepatic stellate cells.
Journal: Free radical biology & medicine
Published: June 29, 2025
TIPS improves survival in patients with cirrhosis and recurrent ascites: a multicenter observational study.
Journal: International journal of surgery (London, England)
Published: June 25, 2025
Corrigendum to "DNA-methylation eraser TET2 activates WTIP expression to suppress an AKT-dependent chemoresistance of gastric cancer" [Neoplasia volume 2025 Apr 24:65:101166].
Journal: Neoplasia (New York, N.Y.)
Published: June 11, 2025
Small-molecule enhancement of METTL3 S-palmitoylation as a therapeutic strategy for osteoarthritis.
Journal: Cell reports
Published: June 05, 2025
Gut microbiota and metabolic signatures of anxiety in ulcerative colitis: a cross-sectional study.
Journal: Therapeutic advances in gastroenterology
Published: May 16, 2025
Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.
Journal: The lancet. Gastroenterology & hepatology
Published: April 22, 2025
DNA-methylation eraser TET2 activates WTIP expression to suppress an AKT-dependent chemoresistance of gastric cancer.
Journal: Neoplasia (New York, N.Y.)
Published: February 22, 2025
Pseudomonas aeruginosa enhances anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8+ T cells.
Journal: Frontiers in immunology
Published: December 31, 2024
Last Updated: 09/26/2026